Fluicell’s response to COVID-19

As the COVID-19 infection spreads across the world, many workplaces struggle to keep activities going while minimizing exposure…

Read more
18 Mar 2020

First sale of Biopixlar and collaboration with University of Canterbury

We are proud to announce the first sale of the Biopixlar® platform to University of Canterbury, NZ. The…

Read more
03 Mar 2020

Promising new receptor modulator affecting cognitive dysfunction

The alpha-7 nicotinic receptor (nAChR) is an acetylcholine receptor with implied importance for long-term memory and with a…

Read more
03 Mar 2020

Biopixlar ready to face key challenges for bioprinting

As the world of bioprinting moves from concepts to actual biological applications, the performance requirements put on emerging…

Read more
13 Feb 2020

Fluicell at BPS 2020

Fluicell is an innovative biotech company with the ambition to create new opportunities for life science. This year,…

Read more
05 Feb 2020

Fluicell welcomes Klaudia Małgorzata Jurczak

Starting in January 2020, Klaudia Małgorzata Jurczak is joining Fluicell to do her Master’s thesis work. Klaudia has…

Read more
04 Feb 2020

NMDAR enhancer with benefits for Alzheimer´s disease

NMDA receptors play subunit-specific roles in synaptic function with connections to neuropsychiatric and neurodegenerative disorders. In the study…

Read more
28 Jan 2020

Student visit at Fluicell

Yesterday we had the great pleasure of receiving a student visit from SBE Student Chapter Chalmers. It was…

Read more
21 Jan 2020

Promising new insights into ion channel function

Researchers at Genentech Inc. have studied the structure and function of voltage-gated sodium channels, using Dynaflow Resolve to…

Read more
17 Dec 2019